Journal of Clinical and Cellular Immunology
Open Access
ISSN: 2155-9899
ISSN: 2155-9899
M.Sc, Research and Development Department (R&D), Biosynthesis Medical, Caracas, Miranda, Venezuela
Research Article
Clinical Study to Verify the Effectiveness and Safety of the Modified Isothymol or Carvacrol Compound against SARS-CoV-2 in COVID-19 Patients
Author(s): Raul A Ojeda*
Background: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019
(COVID-19), none have yet been shown to be efficacious.
Methods: We conducted a double-blind, randomized, placebo-controlled trial of isothymol in adults hospitalized
with COVID-19 with evidence of lower respiratory tract involvement. Patients were randomly assigned to receive
either isothymol (6 mg/ml) or placebo for up to 15 days. The primary outcome was the time to recovery, defined by
either discharge from the hospital or hospitalization for infection-control purposes only.
Results: A double-blind, randomized, controlled trial with placebo and modified isothymol was conducted in adults
who were hospitalized with COVID-19. Patients were randomized to receive isothymol (6 mg/ml) or placebo .. View More»
DOI:
10.35248/2155-9899.22.13.670